04/02/2024: Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study

05/31/2023: Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System

First US patients treated in international PULSAR IDE study to test safety and effectiveness of Globe System.

03/15/2023: Kardium announces first patients treated in PULSAR IDE study of Globe® Pulsed Field System

First patients treated in international, multicenter PULSAR study to test safety and effectiveness of Globe System.

08/05/2021: Kardium selected as Medical/Digital Technology Company of the Year

Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.

07/20/2021: More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory

Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.

01/25/2021: B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public

Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.